ALRN-5281

· Aileron Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALRN-5281, covering 2013-05-30 to 2013-05-30. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Safety Study of ALRN-5281 in Healthy Subjects [Phase 1]